scispace - formally typeset
K

Kai Kappert

Researcher at Humboldt University of Berlin

Publications -  94
Citations -  3455

Kai Kappert is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Platelet-derived growth factor receptor & Neointima. The author has an hindex of 26, co-authored 85 publications receiving 2442 citations. Previous affiliations of Kai Kappert include Free University of Berlin & Charité.

Papers
More filters
Journal ArticleDOI

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

Jonas Schulte-Schrepping, +137 more
- 17 Sep 2020 - 
TL;DR: This study provides detailed insights into the systemic immune response to SARS-CoV-2 infection and it reveals profound alterations in the myeloid cell compartment associated with severe COVID-19.
Journal ArticleDOI

Preferential oxidation of the second phosphatase domain of receptor-like PTP-α revealed by an antibody against oxidized protein tyrosine phosphatases

TL;DR: A generic antibody-based method for detection of oxidation-inactivated PTPs is described and previously unrecognized intrinsic differences between PTP domains to susceptibility to oxidation are demonstrated and mechanisms for regulation of RPTPs with tandem P TP domains are suggested.
Journal ArticleDOI

Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR

TL;DR: A novel redox-sensitive SHP-2–dependent pathway for Ang II in VSMCs through AT1R and Nox1-based NAD(P)H oxidase via two mechanisms, oxidation and phosphorylation is identified, associated with augmented AKT signaling.
Journal ArticleDOI

Liver X Receptor Agonists Suppress Vascular Smooth Muscle Cell Proliferation and Inhibit Neointima Formation in Balloon-Injured Rat Carotid Arteries

TL;DR: It is demonstrated that LXRs are expressed and functional in primary human coronary artery VSMCs (CASMCs), and LXR ligands inhibit VSMC proliferation and neointima formation after balloon injury, and suggest that LXRligands may constitute a novel therapy for proliferative vascular diseases.
Journal ArticleDOI

Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases.

TL;DR: Serum ferritin may be considered both a prognostic and stratifying biomarker that can also contribute to therapeutic decision-making concerning patients with COVID-19 in comparison with other infectious and non-infectious diseases.